RxStrategies Says CVS, Rival Swiping Its Customers
RxStrategies Inc., a leading program administrator for the federal 340B Drug Pricing Program, asked a Florida federal judge Monday for a preliminary injunction to keep CVS and rival Wellpartner from engaging...To view the full article, register now.
Already a subscriber? Click here to view full article